Recruiting Essential Tremor Studies in Erie
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mut...
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Typ...
About Essential Tremor Clinical Trials in Erie
Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.
There are currently 2 essential tremor clinical trials recruiting participants in Erie, PENNSYLVANIA. These studies are seeking a combined 250 participants. Research is being sponsored by Ocugen, Vantage Biosciences Ltd. Clinical trial participation is free and participants receive study-related medical care at no cost.
Essential Tremor Clinical Trials in Erie — FAQ
Are there essential tremor clinical trials in Erie?
Yes, there are 2 essential tremor clinical trials currently recruiting in Erie, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Erie?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Erie research site will contact you about next steps.
Are clinical trials in Erie free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Erie studies also compensate for your time and travel.
What essential tremor treatments are being tested?
The 2 active trials in Erie are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.
Data updated March 2, 2026 from ClinicalTrials.gov